Search clinical trials for: TRx0237
Total 11 results
-
TauRx Therapeutics LtdAvailableAlzheimer Disease
-
TauRx Therapeutics LtdQuotient ClinicalCompletedAlzheimer's Disease
-
TauRx Therapeutics LtdQuotient ClinicalCompletedAlzheimer's Disease
-
TauRx Therapeutics LtdCompletedSafety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label TreatmentAlzheimer DiseaseUnited States, Spain, Poland, Belgium, France, United Kingdom, Italy, Canada
-
TauRx Therapeutics LtdCompletedAlzheimer's DiseaseKorea, Republic of, United States, Spain, United Kingdom, Taiwan, Poland, Malaysia, Singapore, Canada, Croatia, Italy, Australia, Germany, Romania, Russian Federation, Bulgaria
-
TauRx Therapeutics LtdCompletedBehavioral Variant Frontotemporal Dementia (bvFTD)United States, Australia, Canada, Croatia, Poland, Netherlands, United Kingdom, Spain, Germany, Italy, Romania, Singapore
-
Trevena Inc.CompletedAcute Decompensated Heart FailureUnited States, Bulgaria, Poland, Russian Federation, Germany, Romania, Argentina, Canada, Czechia, Hungary, Israel, Slovakia
-
TauRx Therapeutics LtdTerminatedAlzheimer's DiseaseGermany, United Kingdom
-
TauRx Therapeutics LtdCompletedAlzheimer's DiseaseUnited States, Spain, Canada, Belgium, France, Italy, Croatia, Finland, Germany, United Kingdom, Australia, Netherlands
-
Sean CollinsNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedCOVID-19 | Coronavirus Infection | SARS-CoV-2 InfectionUnited States